Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-08-05

Clinical Trial Update: FCR or APL in LRTI - A Single Surgeon Randomized Controlled Trial [NA]

View source ↗

Summary

A single-surgeon randomized controlled trial comparing FCR to APL in osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APL
  • FCR

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Osteoarthritis | NA | Status: WITHDRAWN